Tectal plate gliomas are rare, slow-growing tumors of the midbrain that are discovered predominantly in the pediatric population. Because of their indolent nature, treatment mainly consists of observation and management of hydrocephalus. Unfortunately, a subset of tectal gliomas may exhibit tumor enlargement and disease progression. Currently, there are no established guidelines for predicting future progression of tectal gliomas or the need for tumor-directed treatment. In this paper, the authors present a large case series of tectal plate gliomas with the aim of determining early indicators of tumor progression and the need for tumor-directed treatment in a pediatric population, along with providing their experience in treating progressive tumors.
开云体育世界杯赔率
A retrospective chart review of 170 patients diagnosed with tectal plate glioma from a single institution, of whom 67 were pediatric patients (≤ 18 years of age), was performed. Univariate analysis was used to determine statistically significant predictors of symptomatic disease progression requiring eventual tumor-directed therapy.
RESULTS
The median patient age of the full cohort was 24 years (range 0–73 years). Compared with the pediatric population, the adult population had more instances of incidental lesions (p < 0.001) and lower rates of hydrocephalus (50% vs 84%, p < 0.001). Of the pediatric patients who had ≥ 5 years of follow-up (n = 51), 12 (24%) experienced radiological progression and 13 (25%) required treatment for their tumor. The 1-year, 5-year, and 10-year radiographic progression-free survival (PFS) rates were 98%, 90%, and 86%, respectively. In univariate analysis, lesion involvement of the pons, moderate T1 hypointensity, and moderate contrast enhancement on baseline radiology were significantly associated with worse radiographic PFS. Alternatively, significant predictors of requiring tumor-directed treatment included extraocular eye movement abnormalities at presentation, involvement of the lesion beyond the tectum on baseline radiology, moderate T1 hypointensity, moderate contrast enhancement, and an increase in total lesion size during progression. At the most recent follow-up, 94% of the patients had stable/nonprogressive disease, 2% had progressive disease, and 4% died of tumor progression.
CONCLUSIONS
患者演示影像学进展may not necessarily experience clinical/symptomatic progression or require tumor-directed treatment. Certain patient presentation characteristics and baseline radiographic features may be predictive of worse radiographic PFS or the need for future tumor-directed treatment in the pediatric population. Typically, the natural history of these lesions lends to excellent long-term survival, even in patients who experience clinical progression, should appropriate treatment be initiated.
ABBREVIATIONS
ETV = endoscopic third ventriculostomy;GTR = gross-total resection;ICP = intracranial pressure;PFS = progression-free survival;STR = subtotal resection.
KaufmannA,GerberNU,KandelsD,et al.Management of primary tectal plate low-grade glioma in pediatric patients: results of the multicenter treatment study SIOP-LGG 2004.Neuropediatrics.2018;49(5):314–323.
Kaufmann
A
,
Gerber
NU
,
Kandels
D
,
Management of primary tectal plate low-grade glioma in pediatric patients: results of the multicenter treatment study SIOP-LGG 2004
.Neuropediatrics
.
2018
;
49
(
5
):
314
–
323
.)| false
BaumanMMJ,BhandarkarAR,ZhengCR,et al.Management strategies for pediatric patients with tectal gliomas: a systematic review.Neurosurg Rev.2022;45(2):1031–1039.
Bauman
MMJ
,
Bhandarkar
AR
,
Zheng
CR
,
Management strategies for pediatric patients with tectal gliomas: a systematic review
.Neurosurg Rev
.
2022
;
45
(
2
):
1031
–
1039
.)| false
GassD,DewireM,ChowL,et al.Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae.J Neurooncol.2015;122(1):169–177.
Gass
D
,
Dewire
M
,
Chow
L
,
Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae
.J Neurooncol
.
2015
;
122
(
1
):
169
–
177
.)| false
DağlioğluE,CataltepeO,AkalanN.Tectal gliomas in children: the implications for natural history and management strategy.Pediatr Neurosurg.2003;38(5):223–231.
Dağlioğlu
E
,
Cataltepe
O
,
Akalan
N
.
Tectal gliomas in children: the implications for natural history and management strategy
.Pediatr Neurosurg
.
2003
;
38
(
5
):
223
–
231
.)| false
LiuAPY,HarreldJH,JacolaLM,et al.Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.Acta Neuropathol Commun.2018;6(1):101.
Liu
APY
,
Harreld
JH
,
Jacola
LM
,
Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis
.Acta Neuropathol Commun
.
2018
;
6
(
1
):
101
.)| false
WellonsJCIII,TubbsRS,BanksJT,et al.Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas.开云体育app官方网站下载入口.2002;51(1):63–68.
Wellons
JC
III
,
Tubbs
RS
,
Banks
JT
,
Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas
.开云体育app官方网站下载入口
.
2002
;
51
(
1
):
63
–
68
.)| false
MohmeM,FritzscheFS,MendeKC,et al.Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.Neurosurg Focus.2018;44(6):E15.
Mohme
M
,
Fritzsche
FS
,
Mende
KC
,
Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm
.Neurosurg Focus
.
2018
;
44
(
6
):
E15
.)| false
GrantGA,AvellinoAM,LoeserJD,EllenbogenRG,BergerMS,RobertsTS.Management of intrinsic gliomas of the tectal plate in children. A ten-year review.Pediatr Neurosurg.1999;31(4):170–176.
Grant
GA
,
Avellino
AM
,
Loeser
JD
,
Ellenbogen
RG
,
Berger
MS
,
Roberts
TS
.
Management of intrinsic gliomas of the tectal plate in children. A ten-year review
.Pediatr Neurosurg
.
1999
;
31
(
4
):
170
–
176
.)| false
MazloomA,HodgesJC,TehBS,ChintagumpalaM,PaulinoAC.Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination.Int J Radiat Oncol Biol Phys.2012;84(2):350–354.
Mazloom
A
,
Hodges
JC
,
Teh
BS
,
Chintagumpala
M
,
Paulino
AC
.
Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination
.Int J Radiat Oncol Biol Phys
.
2012
;
84
(
2
):
350
–
354
.)| false
LiKW,RoonprapuntC,LawsonHC,et al.Endoscopic third ventriculostomy for hydrocephalus associated with tectal gliomas.Neurosurg Focus.2005;18(6A):E2.
Li
KW
,
Roonprapunt
C
,
Lawson
HC
,
Endoscopic third ventriculostomy for hydrocephalus associated with tectal gliomas
.Neurosurg Focus
.
2005
;
18
(
6A
):
E2
.)| false
RaminaR,Coelho NetoM,FernandesYB,BorgesG,HonoratoDC,ArrudaWO.Intrinsic tectal low grade astrocytomas: is surgical removal an alternative treatment? Long-term outcome of eight cases.Arq Neuropsiquiatr.2005;63(1):40–45.
Ramina
R
,
Coelho Neto
M
,
Fernandes
YB
,
Borges
G
,
Honorato
DC
,
Arruda
WO
.
Intrinsic tectal low grade astrocytomas: is surgical removal an alternative treatment? Long-term outcome of eight cases
.Arq Neuropsiquiatr
.
2005
;
63
(
1
):
40
–
45
.)| false
KershenovichA,SilmanZ,de RungsD,KoralK,GarganL,WeprinB.Tectal lesions in children: a long-term follow-up volumetric tumor growth analysis in surgical and nonsurgical cases.Pediatr Neurosurg.2016;51(2):69–78.
Kershenovich
A
,
Silman
Z
,
de Rungs
D
,
Koral
K
,
Gargan
L
,
Weprin
B
.
Tectal lesions in children: a long-term follow-up volumetric tumor growth analysis in surgical and nonsurgical cases
.Pediatr Neurosurg
.
2016
;
51
(
2
):
69
–
78
.)| false
MottoleseC,SzathmariA,BeuriatPA,FrappazD,JouvetA,HermierM.Tectal plate tumours. Our experience with a paediatric surgical series.Neurochirurgie.2015;61(2-3):193–200.
Mottolese
C
,
Szathmari
A
,
Beuriat
PA
,
Frappaz
D
,
Jouvet
A
,
Hermier
M
.
Tectal plate tumours. Our experience with a paediatric surgical series
.Neurochirurgie
.
2015
;
61
(
2-3
):
193
–
200
.)| false
WulfovichS,TuckerS,LevyM,CrawfordJR.Novel KRAS mutation in an unusual tectal low-grade glioma.BMJ Case Rep.2021;14(4):e242306.
Wulfovich
S
,
Tucker
S
,
Levy
M
,
Crawford
JR
.
Novel KRAS mutation in an unusual tectal low-grade glioma
.BMJ Case Rep
.
2021
;
14
(
4
):
e242306
.)| false
ChiangJ,LiX,LiuAPY,QaddoumiI,AcharyaS,EllisonDW.Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.Acta Neuropathol.2020;139(3):601–602.
Chiang
J
,
Li
X
,
Liu
APY
,
Qaddoumi
I
,
Acharya
S
,
Ellison
DW
.
Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations
.Acta Neuropathol
.
2020
;
139
(
3
):
601
–
602
.)| false
NagaishiM,NakaeR,FujiiY,et al.Rare clinical presentations of pleomorphic xanthoastrocytoma with a high proliferative index: two case reports.Medicine (Baltimore).2020;99(3):e18880.
Nagaishi
M
,
Nakae
R
,
Fujii
Y
,
Rare clinical presentations of pleomorphic xanthoastrocytoma with a high proliferative index: two case reports
.Medicine (Baltimore)
.
2020
;
99
(
3
):
e18880
.)| false
